Functional Impact of Reconstructive Surgery by Harvesting a Vascularized Free Fibula Flap Postoperatively.
Launched by CENTRE HOSPITALIER UNIVERSITAIRE DIJON · Dec 5, 2022
Trial Information
Current as of February 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a specific surgery called free fibula flap reconstruction, which uses a piece of bone from the leg to help repair complex areas in the face after cancer or injury. The researchers want to understand how this surgery impacts patients' movement and quality of life in the short term (one month after surgery) and medium term (six months after surgery). They aim to identify any difficulties patients might face, such as pain or problems walking, so they can create better rehabilitation programs tailored to individual needs.
To participate in this study, you need to be at least 18 years old and scheduled for this type of surgery at the Dijon University Hospital. You should also be willing to follow the study requirements and provide informed consent. Over about seven months, participants will have three scheduled visits to assess their recovery and overall well-being. This study is important because it will provide valuable information that can help improve recovery strategies for patients undergoing this type of surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All patients eligible for bone reconstruction with a free fibula flap
- • Age ≥ 18 years
- • Procedure scheduled in the plastic and maxillofacial surgery department of the Dijon University Hospital
- • Willingness to comply with the protocol requirements
- • Person having given oral, free and informed consent
- Exclusion Criteria:
- • Person who is not affiliated or not a beneficiary of a social security system
- • Person subject to a legal protection measure (curatorship, guardianship)
- • Person subject to a legal protection measure
- • Pregnant, parturient or breastfeeding woman
- • Major who is incapable or unable to give oral consent
- • Minor
- • Indication for bone reconstruction of a lower limb (e.g. femur) or pelvis
- • Musculoskeletal or neurological disorders causing significant prior impairment of walking (whatever the etiology)
- • Cognitive disorders that prevent the proper understanding of instructions and the completion of questionnaires
- • Non operated patient
About Centre Hospitalier Universitaire Dijon
The Centre Hospitalier Universitaire Dijon (CHU Dijon) is a leading academic medical institution in France, dedicated to advancing healthcare through innovative research and clinical trials. With a focus on patient-centered care, CHU Dijon integrates comprehensive medical services with cutting-edge research initiatives across various specialties. The institution is committed to enhancing clinical outcomes and improving health standards by facilitating rigorous scientific investigations and collaborations with national and international partners. By prioritizing ethical practices and adherence to regulatory standards, CHU Dijon aims to contribute significantly to the development of new therapies and medical technologies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dijon, , France
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials